BLGO
BioLargo, Inc.
Basic Materials · Chemicals · OQX
$0.12
Data: 2026-05-18
✓ ETHICAL PASS

MOAT
HIGH
Data Confidence: 100.0%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$42M
Total market value of the company
-3.29
Based on estimated future earnings — lower means cheaper
Rev Growth
0.0%
Year-over-year revenue change
Profit Margin
0.0%
How much profit the company keeps from each dollar of revenue
0.0%
Return on equity — how efficiently it uses shareholder money
Analyst Target
N/A
Recommendation
N/A
Consensus view from ? analysts covering this stock
About BioLargo, Inc.

Company description not available.

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.0% PASS
Debt must be below 33% of total assets
Cash Ratio
0.0% PASS
Interest-bearing cash below 33% of assets
Receivables
0.0% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

MARKUP
Price trending up with increasing momentum
-0.255
Returns do not compensate for the risk — negative edge
-0.4656
No positive edge detected — the data suggests staying out
-0.519
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-34.1%
Historical annualised return based on price data
-65.6%
Largest peak-to-trough decline — the worst it has been
CRISIS
Elevated risk detected — extreme caution warranted
Days in State
1
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

N/A
52W High
$N/A
52W Low
$N/A
Avg Volume
N/A
Average daily shares traded — higher means easier to buy and sell
N/A
Days it would take all short sellers to cover — higher means more crowded
Short % Float
N/A
0.0%
Annual dividend as a percentage of the share price
$-0.04
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

0.00
Conservative use of debt — low financial risk
Quick Ratio
N/A
Like current ratio but excludes inventory — stricter test
Gross Margin
N/A
Revenue left after cost of goods — higher means pricing power
Operating Margin
N/A
Profit from core operations before interest and tax
N/A
Negative — the business is spending more than it generates
Revenue (TTM)
N/A
Total revenue over the last 12 months
Net Income
N/A
Loss-making — spending exceeds revenue after all costs
Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

Date Insider Title Type Shares Value
2026-03-31 CODE KENNETH REAY Officer and Director 69,444 $11,250
2025-12-31 CALVERT DENNIS PATRICK President 130,222 $24,000
2025-12-31 CODE KENNETH REAY Officer and Director 54,803 $10,100
2025-11-14 CALVERT DENNIS PATRICK President 310,269 $49,643
2025-11-14 CODE KENNETH REAY Officer and Director 313,754 $50,201
2025-07-14 CALVERT DENNIS PATRICK President 169,498 $33,900
2025-07-14 CODE KENNETH REAY Officer and Director 181,253 $36,251
2024-12-31 CODE KENNETH REAY Officer and Director 57,666 $10,957
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-18

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.